Cellosaurus cell line TUBO-P2J (CVCL

Cross-references
Cell line name	TUBO-P2J
Accession	CVCL_2A34
Resource Identification Initiative	To cite this cell line use: TUBO-P2J (RRID:CVCL_2A34)
Comments	Group: Patented cell line. Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00272. Characteristics: Metastatic phenotype. Established from metastatic lung nodules in mice implanted with the parent cell line (PubMed=25179116). Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
Disease	Malignant neoplasms of the mouse mammary gland (NCIt: C21678)
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090) Breed/subspecies: BALB-neuT.
Hierarchy	Parent: CVCL_2A33 (TUBO [Mouse mammary tumor])
Sex of cell	Female
Age at sampling	Age unspecified
Category	Cancer cell line
Publications	Patent=KR101309902B1 Park S.-K., Seo S.-K., Bae S.K., Choi J.-H., Jung H., Park J.-H., Kim T.O., Park S.-G. Metastatic breast cancer cell line TUBO-P2J. Patent number KR101309902B1, 17-Sep-2013 PubMed=25179116; DOI=10.1186/1471-2407-14-647 Song H., Kim T.O., Ma S.Y., Park J.-H., Choi J.-H., Kim J.-H., Kang M.S., Bae S.K., Kim K.H., Kim T.H., Seo S.-K., Choi I.W., Song G.A., Mortenson E.D., Fu Y.-X., Park S. Intratumoral heterogeneity impacts the response to anti-neu antibody therapy. BMC Cancer 14:647.1-647.12(2014)
Encyclopedic resources	Wikidata; Q54973346
Entry history
Entry creation	22-Sep-2015
Last entry update	30-Jan-2024
Version number	6